eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
4/2021
vol. 23
 
Share:
Send email
Share:
Review paper

Differential diagnosis of respiratory viral infections in children in the COVID-19 pandemic time

Ewelina Wawryk-Gawda
1
,
Andrzej Emeryk
1
,
Agnieszka Chojęta
2

  1. Department of Paediatric Pulmonology and Rheumatology, Medical University of Lublin, Lublin, Poland
  2. Medical Laboratory DIAGNOSTYKA, Lublin, Poland
Family Medicine & Primary Care Review 2021; 23(4): 501–507
DOI: https://doi.org/10.5114/fmpcr.2022.110372
Online publish date: 2021/12/30
Article file
- 20 FM&PCR 4 21 - R - Wawryk-Gawda - 943 - Differential.pdf  [0.53 MB]
Get citation
 
PlumX metrics:
 
1. Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 2010; 23(1): 74–98, doi: 10.1128/CMR.00032-09.
2. Annamalay A, Le Souëf P. Viral-bacterial interactions in childhood respiratory tract infections. Viral Infections in Children 2017; 1: 193–214, doi: 10.1007/978-3-319-54033-7_8.
3. Nelson PP, Papadopoulos NG, Skevaki C. Respiratory viral pathogens. Reference Module in Biomedical Sciences 2020; B978-0-12-801238-3.11635-6, doi: 10.1016/B978-0-12-801238-3.11635-6.
4. Zieliński R, Zakrzewska A. Ostre infekcje górnych dróg oddechowych u dzieci – podział morfologiczny, diagnostyka i terapia. Forum Med Rodz 2010; 4(5): 366–371 (in Polish).
5. Charlton CL, Babady E, Ginocchio CC, et al. Practical guidance for clinical microbiology laboratories: viruses causing acute respiratory tract infections. Clin Microbiol Rev 2019; 32(1): e00042–e00018.
6. Kuchar E, Miśkiewicz K, Nitsch-Osuch A, et al. Pathophysiology of clinical symptoms in acute viral respiratory tract infections. Pulmonary Infection 2015; 857: 25–38.
7. Mazurek H, Mazurek-Durlak Z. Zakażenia układu oddechowego. Zagadnienia ogólne. In: Mazurek H, ed. Zakażenia układu oddechowego u dzieci. Warszawa: Medical Tribune Polska; 2014: 9–62 (in Polish).
8. Taylor S, Lopez P, Weckx L, et al. Respiratory viruses and influenza-like illness: epidemiology and outcomes in children aged 6 months to 10 years in a multi-country population sample. J Infect 2017; 74(1): 29–41.
9. Conto F De, Conversano F, Medici MC, et al. Epidemiology of human respiratory viruses in children with acute respiratory tract infection in a 3-year hospital-based survey in Northern Italy. Diagn Microbiol Infect Dis 2019; 94(3): 260–267.
10. Ambrosioni J, Bridevaux PO, Wagner G, et al. Epidemiology of viral respiratory infections in a tertiary care centre in the era of molecular diagnosis, Geneva, Switzerland, 2011–2012. Clin Microbiol Infect 2014; 20(9): 578–584, doi: 10.1111/1469-0691.12525.
11. Bonzel L, Tenenbaum T, Schroten H, et al. Frequent detection of viral coinfection in children hospitalized with acute respiratory tract infection using a real-time polymerase chain reaction. Pediatr Infect Dis J 2008; 27: 589–594.
12. Calvo C, Aguado I, García-García ML, et al. Grupo de Estudio de Sibilancias Recurrentes. Infecciones virales respiratorias en una cohorte de niños durante el primer año de vida y su papel en el desarrollo de sibilancias. An Pediatr (Barc) 2017; 87(2): 104–110, doi: 10.1016/j.anpedi.2016.08.002 (in Spanish).
13. Morikawa S, Kohdera U, Hosaka T, et al. Seasonal variations of respiratory viruses and etiology of human rhinovirus infection in children. J Clin Virol 2015; 73: 14–19, doi: 10.1016/j.jcv.2015.10.001.
14. Prasad S, Lownik E, Ricco J. Viral infections of the respiratory tract. Fam Med 2016; 17: 507–517.
15. Jesenak M, Ciljakova M, Rennerova Z, et al. Recurrent respiratory infections in children – definition, diagnostic approach, treatment and prevention. In: Martãn-Loeches I, ed. Bronchitis. Rijeka: InTech; 2011: 119–148.
16. Jung A. Zależności pomiędzy alergią a infekcjami układu oddechowego u dzieci – możliwości profilaktyki i terapii. Pediatr Med Rodz 2009; 5(3): 204–210 (in Polish).
17. Szczawińska-Popłonyk A, Samara H, Bręborowicz A, et al. The importance of studying B-cell surface markers in children with defective biosynthesis of antibodies. Alerg Astma Immunol 2012; 17(2): 97–102.
18. Vissing NH, Chawes BL, Rasmussen MA, et al. Epidemiology and risk factors of infection in early childhood. Pediatrics 2018; 141(6): e20170933, doi: 10.1542/peds.2017-0933.
19. Frank NM, Lynch KF, Uusitalo U, et al. The relationship between breastfeeding and reported respiratory and gastrointestinal infection rates in young children. BMC Pediatr 2019; 19(1): 339, doi: 10.1186/s12887-019-1693-2.
20. Barrett B. Viral upper respiratory infection. Integrative Medicine 2018; 18: 170–179.
21. Markowska-Daniel I, Mickiewicz M, Witkowski L, et al. Charakterystyka nowego wirusa grypy typu D. Med Weter 2016; 72(9): 531–535 (in Polish).
22. Zakład Epidemiologii Chorób Zakaźnych i Nadzoru, Pracownia Monitorowania i Analizy Sytuacji Epidemiologicznej. Zachorowania i podejrzenia zachorowań na grypę w Polsce [cited 1.02.2021]. Available from URL: http://wwwold.pzh.gov.pl/oldpage/epimeld/grypa/index.htm (in Polish).
23. Rządowe Centrum Bezpieczeństwa. Grypa w sezonie epidemicznym 2018–2019 w Polsce i Europie [cited 1.02.2021]. Available from URL: https://rcb.gov.pl/grypa-w-sezonie-epidemicznym-2018-2019-w-polsce-i-europie/ (in Polish).
24. Emeryk A, Emeryk-Maksymiuk J, Jędrzejewski A. Nawrotowe zakażenia dróg oddechowych czy alergiczny nieżyt nosa? Alergoprofil 2019; 15: 1–5 (in Polish).
25. Epperson S, Davis CT, Brammer L, et al. Update: Influenza Activity – United States and Worldwide, May 19–September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine. MMWR Morb Mortal Wkly Rep 2019; 68(40): 880–884, doi: 10.15585/mmwr.mm6840a3.
26. Ghebrehewet S, MacPherson P, Ho A. Influenza. BMJ 2016; 355: i6258, doi: 10.1136/bmj.i6258.
27. Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza. Clin Infect Dis 2019; 68(6): e1–e47, doi: 10.1093/cid/ciy866.
28. Lee FEH, Treanor JJ. Viral Infections. Murray and Nadel’s Textbook of Respiratory Medicine. 2016: 527–556, e15, doi: 10.1016/B978-1-4557-3383-5.00032-4.
29. Guibas GV, Papadopoulos NG. Viral upper respiratory tract infections. Viral Infections in Children, II. 2017, 5: 1-25.
30. Guibas GV, Papadopoulos NG. Viral upper respiratory tract infections. In: Green R, ed. Viral infections in children. Vol. II. Cham: Springer; 2017, doi: 10.1007/978-3-319-54093-1_1.
31. Doniec Z, Mastalerz-Migas A, Jackowska T, et al. Recommendations for the treatment of INFLUENZA in children for primary care physicians – COMPAS INFLUENZA. Fam Med Prim Care Rev 2019; 21(2): 189–198, doi: 10.5114/fmpcr.2019.82984.
32. Schweitzer JW, Justice NA. Respiratory Syncytial Virus Infection (RSV) [Updated 2020 Jul 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.
33. Barr R, Green CA, Sande CJ, et al. Respiratory syncytial virus: diagnosis, prevention and management. Ther Adv Infect Dis 2019; 6: 2049936119865798, doi: 10.1177/2049936119865798.
34. Prejsnar-Rusyn P, Hajkuś R, Leszczyńska K, et al. Alergie. Co nowego w objawowym leczeniu alergicznego zapalenia błony śluzowej nosa i spojówek oraz pokrzywki. Analiza Przypadków. Pediatria 2018; 2 (in Polish).
35. Yen CY, Wu WT, Chang CY, et al. Viral etiologies of acute respiratory tract infections among hospitalized children – a comparison between single and multiple viral infections. J Microbiol Immunol Infect 2019; 52(6): 902–910, doi: 10.1016/j.jmii.2019.08.013.
36. Szczawińska-Popłonyk A. The immune response to respiratory syncytial virus infection. Alerg Astma Immunol 2008; 13(4): 208–216.
37. Edwards KM, Zhu Y, Griffin MR et al. Burden of human metapneumovirus infection in young children. N Engl J Med 2013; 368(7): 633–643.
38. Heikkinen T, Österback R, Peltola V, et al. Human Metapneumovirus infections in children. Emerg Infect Dis 2008; 14(1): 101–106.
39. Wilkesmann A, Schildgen O, Eis-Hübinger AM, et al. Human Metapneumovirus in hospitalized children – a review. Klin Padiatr 2007; 219(2): 58–65.
40. Zhou L, Zheng S, Xiao Q, et al. Single detection of human bocavirus 1 with a high viral load in severe respiratory tract infections in previously healthy children. BMC Infect Dis 2014; 14: 424, doi: 10.1186/1471-2334-14-424.
41. Peltola V, Soderlund-Venermo M, Jartii T. Human Bocavirus infections. J Ped Inf Dis 2013; 32(2): 178–179.
42. Abramczuk E, Gordon M, Jahnz-Różyk K, et al. Ludzkie wirusy Boca – nowe parwowirusy wywołujące zakażenia u ludzi. Forum Zakażeń 2015; 6(1): 43–47 (in Polish).
43. Saleem H, Rahman J, Aslam N, et al. Coronavirus Disease 2019 (COVID-19) in children: vulnerable or spared? A systematic review. Cureus 2020; 12(5): e8207, doi: 10.7759/cureus.8207.
44. Ciuca IM. COVID-19 in children: an ample review. Risk Manag Healthc Policy 2020; 13: 661–669, doi: 10.2147/RMHP.S257180.
45. She J, Liu L, Liu W. COVID-19 epidemic: disease characteristics in children. J Med Virol 2020; 92(7): 747–754, doi: 10.1002/jmv.25807.
46. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 2020; 109(6): 1088–1095, doi: 10.1111/apa.15270.
47. Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J 2020; 39(5): 355–368, doi: 10.1097/INF.0000000000002660.
48. Yamamoto L, Santos EH dos, Pinto LS, et al. SARS-CoV-2 infections with emphasis on pediatric patients: a narrative review. Rev Inst Med Trop Sao Paulo 2020; 62: e65, doi: 10.1590/S1678-9946202062065.
49. Samoliński B, Arcimowicz M, Buczyłko K, et al. Polskie Standardy Leczenia Nieżytów Nosa – PoSLeNN. Kraków: Medycyna Praktyczna; 2013.
50. Wishaupt JO, Ploeg T van der, Groot R de, et al. Single- and multiple viral respiratory infections in children: disease and management cannot be related to a specific pathogen. BMC Infect Dis 2017; 17(1): 62, doi: 10.1186/s12879-016-2118-6.
51. Walsh EE. Respiratory syncytial virus infection: an illness for all ages. Clin Chest Med 2017; 38(1): 29–36, doi: 10.1016/j.ccm.2016.11.010.
52. Troullos E, Baird L, Jayawardena S. Common cold symptoms in children: results of an Internet-based surveillance program. J Med Internet Res 2014; 16(6): e144.
53. Hryniewicz W, Albrecht P, Radzikowski A, eds. Rekomendacje postępowania w pozaszpitalnych zakażeniach układu oddechowego 2016. Warszawa: Narodowy Instytut Leków; 2016. Available from URL: http://antybiotyki.edu.pl/wp-content/uploads/Rekomendacje/Rekomendacje2016.pdf (in Polish).
54. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005; 5(11): 718–725.
55. Samoliński B, Krzych-Fałta E, Wojas O, et al. COVID-19 – recommendations for allergists and ENT specialists. Alergoprofil 2020; 1(16): 3–7, doi: 10.24292/01.AP.161311320 (in Polish).
56. Thompson M, Vodicka TA, Blair PS, et al. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ 2013; 347: f7027.
57. Aabenhus R, Jensen JUS, Jørgensen KJ. Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database Syst Rev 2014; 11: CD010130, doi: 10.1002/14651858.CD010130.pub2.
58. Tonkin-Crine SK, Tan PS, Hecke O van, et al. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews. Cochrane Database Syst Rev 2017; 9(9): CD012252, doi: 10.1002/14651858.CD012252.pub2.
59. Srugo I, Klein A, Stein M, et al. Validation of a novel assay to distinguish bacterial and viral infections. Pediatrics 2017; 140(4): e20163453, doi: 10.1542/peds.2016-3453.
60. Murdoch DR, Werno AM, Jennings LC. Microbiological diagnosis of respiratory illness: recent advances. Kendig’s Disorders of the Respiratory Tract in Children 2019: 396–405, doi: 10.1016/B978-0-323-44887-1.00022-5.
61. Jaguś P, Chorostowska-Wynimko J, Roży A. Diagnostyka wybranych zakażeń wirusowych układu oddechowego. Pneumonol Alergol Pol 2010; 78, 1: 47–53.
62. Hansen G, Marino J, Wang ZX, et al. Clinical performance of the point-of-care cobas Liat for detection of SARS-CoV-2 in 20 minutes: a multicenter study. J Clin Microbiol 2020; 25: JCM.02811-20, doi: 10.1128/JCM.02811-20.
63. Coronavirus Disease 2019 (COVID-19) Emergency use authorizations for medical devices. In vitro diagnostics EUAs [cited 1.02.2021]. Available from URL: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas#individual-antigen.
64. Scohy A, Anantharajah A, Bodéus M, et al. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol 2020; 129: 104455, doi: 10.1016/j.jcv.2020.104455.
65. Lambert-Niclot S, Cuffel A, Le Pape S, et al. Evaluation of a rapid diagnostic assay for detection of SARS-CoV-2 antigen in nasopharyngeal swabs. J Clin Microbiol 2020; 58(8): e00977–e00920, doi: 10.1128/JCM.00977-20.
Copyright: © 2021 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.